@elonmusk@xai What about cancer researchers - guess those engineers were the ones who MADE those anti-cancer treatments? Did not know that. Like bridge like cancer therapy.
@al_xdpg I think I saw a volume shelf at that level as well and with low volume daily candles it had me wondering if we would have the volume to cross this level. Don’t always need volume for up days but seems more important at this level and given recent trend.
@RoyLMattox I have been comparing the daily volumes to the moving average.. currently last several days below average trading days with decreasing volume.. should be interesting to see if this pattern can change and in what direction. thanks
@t1alpha Similarly, when the relative strength of the tech sector to index fund goes up, but all other sectors RS to index fund decrease the day of the breath trust… does it count
@chatgpt_toolbox I enjoy using it. Would be interesting if could also work on Mac ChatGPT app. I often use with chrome but sometimes
Mac app is best use of ChatGPT
@Andre_AGTC One thing i noticed about AXSM, ITCI, ALKS is they are testing candidates that are modifications of existing treatments in terms of mechanism.. rather than an entirely different mechanism of action like RLMD's low-affinity antagonism of NDMAr.
@paras_biotech Will see if the Nov-April seasonality, drop in interest rates, yields and other factors can change the performance picture for healthcare.
@Andre_AGTC It’s good BHVN has a diverse pipeline. The SCA treatment seems non-mechanistic similar to other Neurodegenerstive treatments but did work in one good sized. Phase 3.